1 The agonist action of morphine on membranes prepared from human neuroblastoma SH-SY5Y cells was measured by an increase in the binding of the GTP ]enkephalin (DAMGO, 10 mM) for 48 h aorded a greater eect than treatment with morphine. The maximal agonist eect of morphine was reduced to 58.9+6% of that seen in control cells while the maximal eect of DAMGO was reduced to 62.8+4%. There was a complete loss of agonist activity for pentazocine. 4 The development of tolerance was complete within 24 h and was blocked by naloxone and by the nonselective protein kinase inhibitor H7, but not by the putative b-adrenoceptor kinase (b-ARK) inhibitor suramin. 5 The observed tolerance eect was accompanied by a down-regulation of m-opioid receptors determined by a decrease in the maximal binding capacity for the opioid antagonist 
Introduction m-Opioid receptors belong to the family of 7-transmembrane domain receptors which couple to heteromeric G proteins (Uhl et al., 1993) . Continual exposure of opioid receptors to agonists leads to a tolerance caused by an initial desensitization of the receptor due to uncoupling, followed by down-regulation as the number of cell surface receptors decreases. The actual molecular mechanisms governing these processes are unclear, though phosphorylation is believed to play an important role (Nestler, 1993) .
m-Opioid receptors are expressed, along with a lesser number of d-opioid receptors, on SH-SY5Y human neuroblastoma cells (Kazmi & Mishra, 1987; Yu & Sadee, 1988) and are negatively coupled to adenylyl cyclase (Yu & Sadee 1988) . Differentiation of SH-SY5Y cells with retinoic acid leads to an upregulation of these receptors (Yu & Sadee, 1988) . Chronic treatment of such dierentiated cells with morphine leads to a decrease in the capacity of m-opioid agonists to inhibit the accumulation of adenosine 3' : 5'-cyclic monophosphate (cyclic AMP) (Yu & Sadee, 1988; Carter & Medzihradsky 1993a) and to mediate inhibition of the N-type Ca 2+ current (Kennedy & Henderson, 1991) . These eects are accompanied by a decrease in the maximal binding capacity of m-ligands in cell membranes (Zadina et al., 1994) . Similar ®ndings have been obtained in undierentiated SH-SY5Y cells (Carter & Medzihradsky, 1992; Prather et al., 1994) .
The agonist action of m-opioids can be functionally demonstrated in membranes from undierentiated SH-SY5Y cells by an increase in the level of binding of the guanosine 5'-triphosphate (GTP) analogue [ (Traynor & Nahorski, 1995) . This follows coupling of agonist-occupied receptors to G o and G i proteins, as evidenced by the sensitivity of the system to pertussis toxin, and allows dierentiation of opioids of varying intrinsic activity. In this study changes induced in this coupling mechanism following chronic morphine treatment were assessed as a reduction in the ability of opioid agonists to stimulate [ .
Methods

Cell culture and membrane preparation
Undierentiated human neuroblastoma SH-SY5Y cells (passage number 78 ± 100) were cultured in Minimum Essential Medium supplemented with 10% foetal calf serum and antibiotics, as described previously (Traynor & Nahorski, 1995) . Brie¯y, cells were grown in monolayers to con¯uency at 378C in a humidi®ed 5% CO 2 atmosphere. The cells were harvested in HEPES (N-[2-hydroxyethyl] piperazine-N'-[2-ethanesulphonic acid], 20 mM, pH 7.4)-buered saline containing 1 mM EDTA, dispersed by agitation and collected by centrifugation at 5006g. For [ 35 S]-GTPgS assays the cell pellet was suspended in a buer of 20 mM HEPES, pH 7.4, 100 mM NaCl and 10 mM MgCl 2 ; 6H 2 O (buer A) and homogenized with a tissue tearor (Biospec Products). The resultant homogenate was centrifuged at 50,000 6 g and the pellet collected, washed in buer A and recentrifuged. The pellet was ®nally resuspended in buer A to give a protein concentration of between 100 ± 200 mg ml 71 (Lowry et al., 1951) . All procedures were performed at 48C and membranes freshly prepared. In experiments to determine opioid binding in membranes, buer A was replaced with 50 mM Tris-HCl buer, pH 7.4, in all procedures and the ®nal pellet was resuspended to a protein concentration of approximately 100 mg ml 71 . To examine the eect of chronic opioid exposure con¯uent cells were fed ®ve days after passaging, and morphine (10 mM), DAMGO (10 mM) or sterile vehicle (water), was added to the medium. Two days later, unless otherwise stated, the cells were harvested and membranes prepared as above. Morphine (10 mM) or DAMGO (10 mM) was added to control cells 5 min before harvesting to control for any eects due to residual opioid (Yu & Sadee, 1988; Zadina et al., 1993) .
[
S]-GTPgS binding assays
SH-SY5Y cell membranes (100 ± 200 mg protein), prepared as described above, were incubated in buer A containing [
35 S]-GTPgS (80 pM), GDP (3 mM) and varying concentrations of opioid (1 ± 10,000 nM) in a total volume of 1 ml, for 60 min at 308C as described previously (Traynor & Nahorski, 1995 
Opioid binding assays
Cell membranes (100 mg of protein) prepared as described above were incubated in 50 mM Tris-HCl buer, pH 7.4, with varying concentrations (0.04 ± 10 nM) of the m-opioid agonist [ 3 H]-DAMGO, or the nonselective antagonist [ 3 H]-diprenorphine, in a total volume of 1 ml, for 40 min at 258C, as described previously (Traynor & Wood, 1989 (Munsen & Rodbard, 1980) and anities from competition assays (K i ) calculated with the Cheng and Prusso equation (Cheng & Prusso, 1973 
Results
Morphine stimulated the binding of [
35 S]-GTPgS (80 pM) to membranes from undierentiated SH-SY5Y cells in a concentration-dependent manner, as shown previously (Traynor & Nahorski, 1995) , aording an EC 50 of 76.1+9.7 nM (n=9) and a maximal stimulation of 30 fmol of [ (Table 1) .
When the cells were incubated with morphine (10 mM) for 48 h in the presence of naloxone (10 mM) there was no change (Aloyo, 1995) . To determine if H7 was acting by interfering with the binding of morphine to m-opioid receptors in whole SH-SY5Y cells competition experiments against [ 3 H]-diprenorphine in Krebs-HEPES buer were performed. However, the anity (K i ) of H7 for the m-opioid receptor was 4500 mM compared to the K i for morphine, determined under the same conditions, of 566+38 nM (Hill coecient of 0.89+0.10). In contrast to H7, incubation of SH-SY5Y cells with the putative b-adrenoceptor kinase (b-ARK) inhibitor suramin (Miller et al., 1993) (Figure 4) . The ability of the agonist DAMGO to compete for 
Discussion
Binding the m-opioid agonists morphine and DAMGO to membranes from undierentiated SH-SY5Y cells caused an increase in the binding of the GTP analogue [ 35 S]-GTPgS. The maximal stimulation induced by pentazocine was less, con®rming the partial agonist nature of this opioid. These observations are similar to those previously obtained (Traynor & Nahorski, 1995) but the compounds were less potent, for example the EC 50 value for morphine was 2.7 fold lower and for pentazocine was 1.4 fold lower. However, binding assays with the selective m-opioid agonist [
3 H]-DAMGO revealed a lower number of opioid m-receptors in the SH-SY5Y cells used in these studies (140 fmol mg 71 protein) compared to previous studies (254 fmol mg 71 protein). The shift to lower potency with a reduction in receptor number agrees with accepted theories of receptor occupancy (Kenakin, 1993) and con®rms the usefulness of the system for investigating pharmacological concepts. The tritiated antagonist [ 3 H]-DAMGO will only bind to m-opioid receptors in a high anity state (Carroll et al., 1988; Traynor & Wood, 1989 (Cheng et al., 1995) .
Incubation of the SH-SY5Y cells with morphine (10 mM) or DAMGO (10 mM) for 48 h led to a decrease in the ability of subsequently added m-opioid agonists to stimulate the binding of [ ]-diprenorphine which labels both coupled and uncoupled states of the m-receptor measures total receptor numbers, and con®rms an actual loss in membranebound receptor number, as shown in both undierentiated (Carter & Medzihradsky, 1992; Prather et al., 1994) and retinoic acid-dierentiated SH-SY5Y cells (Zadina et al., 1994) , rather than just a desensitization and uncoupling from G 35 S]-GTPgS binding diered only by 2 ± 3 fold. It will be intriguing to discover if the mopioid binding site population resistant to down-regulation relates to the ®nding that the eects of opioids on pupil size and the constipating eects of opioids are generally resistant to tolerance (Adams & Holtzman, 1990) .
A reduction in receptor number, as observed following morphine or DAMGO pretreatment of the cells, would be expected to result in a shift to the right in the concentrationeect curve for a full agonist, accompanied by a reduction in the maximal eect for a less ecacious compound (Kenakin, 1993) . In the locus coeruleus m-opioid receptors couple to an inwardly rectifying K + channel. Chronic treatment of rats with morphine results in a shift in the concentration curve for DAMGO acting on this channel, while for the less ecacious normorphine a¯attening of the dose-eect curve occurs (Christie et al., 1987) . Similarly, chronic morphine treatment of retinoic acid dierentiated SH-SY5Y cells leads to a 7 fold shift in the ability of DAMGO to inhibit an N-type Ca 2+ current in these cells, whereas morphine shows a reduction in the maximal eect (Kennedy & Henderson, 1991) , and there is a reduction in the maximal inhibition of adenylyl cyclase by morphine (Yu & Sadee, 1988) . In contrast, the present ®ndings in undierentiated SH-SY5Y cells show both a shift in the EC 50 value and a decrease in the maximal response, not only for morphine but also for the highly ecacious agonists DAMGO and fentanyl. Although unexpected, similar ®ndings have been obtained. Thus, in retinoic acid-dierentiated SH-SY5Y cells chronically treated with DAMGO, a decreased maximal eect of DAMGO inhibition of adenylyl cyclase and stimulation of GTPase is seen (Carter & Medzihradsky, 1993a) . However, this eect is not seen with chronic morphine pretreatment. On the other hand, chronic exposure of 7315c pituitary cells to morphine for 3 h results in a reduction in the maximal ability of the full-agonist [D-Ala 2 , D-Leu 5 ]enkephalin to reduce adenylyl cyclase activity and, with longer exposure to morphine, a complete loss of the activity (Puttfarcken et al., 1988) .
The ecacy of drugs is not only related to the drug but to tissue factors. For example, morphine is a full agonist in the guinea-pig ileum, a partial agonist in the mouse vas deferens, but an antagonist in the rat vas deferens (Traynor, 1994) . These eects can be explained by dierences in receptor reserve. A low m-opioid receptor reserve in SH-SY5Y cells, as observed for the cloned m-receptor expressed in CHO or BHK cells (Pak et al., 1996) , could explain the present ®ndings. However, there is evidence for a m-receptor reserve in SH-SY5Y cells since the ratio of K i to EC 50 values for stimulation of [ (Traynor & Nahorski, 1995) . In addition, at least in retinoic acid treated cells, reduction in receptor number by 50% with the alkylating agent b-chlornaltexamine has no eect on the maximal inhibition of adenylyl cyclase and a 90% reduction in receptor number following chronic treatment with levorphanol only reduces the maximal response by a small amount (Carter & Medzihradsky, 1993a) . Other tissue factors altered by the tolerance process may therefore be responsible for the reduction in maximal [ 35 S]-GTPgS binding. It is known that the m-opioid receptor in undierentiated SH-SY5Y cells activates several dierent, pertussis-toxin sensitive, heterotrimeric G proteins (Laugwitz et al., 1993) . The [ 35 S]-GTPgS binding assay does not distinguish these dierent G proteins but rather represents a measure of all G proteins activated following agonist occupation of a particular receptor. The reduced maximal response to the full agonist DAMGO may indicate that the loss of receptors is accompanied by a reduction in associated G proteins or altered function of these G proteins, such that there is a reduced capacity for [ 35 S]-GTPgS binding. Indeed, chronic treatment of rat striatal neurones with morphine causes a reduction in the number of inhibitory G-proteins (Van Vliet et al., 1993) and chronic DAMGO treatment of retinoic acid dierentiated SH-SY5Y cells decreases the content of G oa , the G protein responsible for coupling opioid m-receptors to adenylyl cyclase in these cells (Carter & Medzihradsky, 1993b) . However, any such G protein changes would have to be speci®c for the mopioid receptor since in SH-SY5Y cells tolerance to m-opioid agonists appears to be homologous (Kennedy & Henderson, 1991; Lameh et al., 1992; Prather et al., 1994) .
S]-GTPgS binding is 41
In naive SH-SY5Y cells naloxone showed a small degree of activity resulting in stimulation of [ (Chidiac et al., 1996) . Such an inverse agonist action of naloxone would lead to a reduction in the level of activated G protein and could be responsible for the overshoot in cyclic AMP production seen with naloxone following chronic treatment of SH-SY5Y cells with morphine (Wang et al., 1994) .
Opioid receptors may be substrates for b-adrenoceptor kinase (b-ARK). Indeed, k-receptors in cells with dominant negative mutations of b-ARK do not down-regulate or desensitize (Raynor et al., 1994) . The present experiments have shown that the putative b-ARK inhibitor suramin at 10 mM, that is 100 times higher than its reported activity in A 431 cells (Miller et al., 1993) , did not block the development of tolerance as determined by changes in [ the non-speci®c protein kinase inhibitor H7 (Hidaka et al., 1984) was able to prevent the eects of chronic morphine pretreatment, supporting evidence that phosphorylation is a key step in receptor desensitization and the development of tolerance to opioids (Childers, 1991; Nestler, 1993; Raynor et al., 1994; Wang et al., 1994; Pei et al., 1995; Ueda et al., 1995) . It is possible that the observed eects of H7 are unrelated to an inhibition of kinase enzymes, but are due to a direct action of the compound at opioid receptors (Aloyo, 1995) . However, H7 displaced [ 3 H]-diprenorphine speci®cally bound to whole cells under physiological conditions (Krebs buer) with a K i of 4500 mM, whilst the K i for morphine was 566 nM, similar to values previously obtained in SH-SY5Y cells and guinea-pig brain membranes (Carroll et al., 1988) . At the level of morphine (10 mM) used for the chronic studies it was determined, by use of the Cheng and Prusso equation (Cheng & Prusso, 1973) , that approximately 5 mM H7 would be required to displace 50% of the morphine from opioid receptors. It is unlikely, therefore, that H7, at the concentration used, prevented the eects of chronic morphine treatment by direct competition at m-opioid binding sites. Thus, unlike previous ®ndings in non-physiological buers (Aloyo, 1995) , the results do indicate that H7 can be used to study phosphorylation processes associated with opioid receptor systems.
In conclusion, the results show that the stimulation of [ 35 S]-GTPgS binding mediated by m-opioid receptors in SH-SY5Y cells is sensitive to long-term exposure to m-agonists. A tolerance develops that is manifested by a small reduction in agonist potency together with a reduced maximal eect, even for a highly ecacious agonist such as DAMGO. The mechanism of this tolerance involves a reduction in receptor number and may require altered function of inhibitory G protein. This appears to involve phosphorylation of components within the receptor and/or G protein systems. Since guanine nucleotide exchange is the ®rst measurable biochemical event following agonist occupation of seven-transmembrane domain G protein-linked receptors, the binding of [ 35 S]-GTPgS can be used as a functional measure to probe readily mechanisms behind the development of tolerance very early in the signal-transduction cascade.
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